Multi-stakeholder Alliance

The multi-stakeholder Alliance is governed by principles and values that underpin the joint working interactions, as well as the objectives and modus operandi for TRANSFORM.

Members

Observers

European Medicines Agency

In individual capacity:

  • Marc Dooms, Senior Orphan Drug Pharmacist, University Hospitals Leuven
  • Stuart Faulkner, Programme and Operations Manager at the Center for the Advancement of Sustainable Medical Innovation (CASMI), Oxford University

@TRANSFORM_CGT on Twitter Follow us →

TRANSFORM MEP @TomislavSokol is giving a video address at the GAPP JA Final Dissemination Conference, highlighting TRANSFORM’s plans to discuss the revision of the BTC legislation in the first semester of 2022. #MEPsforATMPs ➡️ see the video: https://t.co/OBjJ55qXPh
21 January at 11:35am
Today’s Oslo Medicines Initiative webinar will focus on one of TRANSFORM’s priority issues:“Models for financing novel medicines to support innovation as a global public good”. This is crucial for safe and timely patient access to ATMPs. TRANSFORM looks forward to the discussion. https://t.co/OhrxFe8HvW
20 January at 10:20am
Check out this webinar series hosted by the Oslo Medicines Initiative, with interventions from a range of stakeholders on how to improve access to novel medicines in the WHO European region. @WHO_Europe https://t.co/82MrcaXkFr
13 January at 12:40pm